The Relationship Between Serum and Tissue Levels of IL-13 and TYK2 in Colorectal Cancer Patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Relationship Between Serum and Tissue Levels of IL-13 and TYK2 in Colorectal Cancer Patients

Published:2024-09-09 Issue: Volume: Page:1-14
ISSN:0882-0139
Container-title:Immunological Investigations
language:en
Short-container-title:Immunological Investigations

Author:

Mozooni Zahra¹,Shahmohammadi Alireza²,Golestani Nafiseh³,Bahadorizadeh Leyla¹⁴

Affiliation:

1. Institute of Immunology and Infectious Diseases, Antimicrobial Resistance Research Center, Iran University of Medical Sciences, Tehran, Iran

2. School of Medicine, Iran University of Medical Sciences, Tehran, Iran

3. Department of Biochemistry, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran

4. Department of Internal Medicine, Iran University of Medical Sciences, Tehran, Iran

Funder

Deputy of Research, Iran University of Medical Sciences

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/08820139.2024.2399581

Reference27 articles.

1. Quality of Life and Psychological Wellbeing of Colorectal Cancer Survivors in the KSA

2. Healthy immune response to allergens: T regulatory cells and more

3. High Expression of IL-13 Receptor α2 in Colorectal Cancer Is Associated with Invasion, Liver Metastasis, and Poor Prognosis

4. Interleukins 4 and 13 and Their Receptors Are Differently Expressed in Gastrointestinal Tract Cancers, Depending on the Anatomical Site and Disease Advancement, and Improve Colon Cancer Cell Viability and Motility

5. IL-4 and IL-13 employ discrete signaling pathways for target gene expression in alternatively activated monocytes/macrophages

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP